Published • loading... • Updated
Ardelyx (ARDX) Faces Securities Class Action
Summary by STL News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Ardelyx (ARDX) Faces Securities Class Action
WALTHAM, MA – October 21, 2026 (STL.News) Ardelyx Inc. (NASDAQ: ARDX), a Massachusetts-based biopharmaceutical company, is facing a federal securities class action lawsuit alleging that the company and certain executives misled investors about its commercial growth prospects, prescription reimbursement challenges, and projected revenue from two pharmaceutical products. The lawsuit follows a nearly 18% decline in […] This News Ardelyx (ARDX) Face…
·Missouri, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
